DUDerya Unal

Derya Unal

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Derya Unal has a total of 276 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    NSAID Tolerance Can Be Restored in NECD Even in the Absence of Complete Remission of Urticaria

    by Merve Hormet Igde, Pelin Korkmaz, Semra Demir, Osman Ozan Yegit, Derya Ünal, Merve Dilşad Atasever, Ayşe Feyza Aslan, Leyla Bölek, Selin Ece Güzel, Nevzat Kahveci, et al.

    Background/Aim: Data on the course of nonsteroidal anti‐inflammatory drug (NSAID) hypersensitivity in NSAID‐exacerbated cutaneous disease (NECD) are limited. We aimed to evaluate NSAID tolerance in NECD patients with well‐controlled urticaria. Methods: 142 patients with well‐controlled urticaria [Urticaria Control Test (UCT) ≥ 12; Urticaria Activity Score over 7 days (UAS7) ≤ 6] underwent a single blind, placebo‐controlled acetylsalicylic acid (ASA) provocation test. Patients were categorized into three groups based on their treatment; omalizumab, antihistamine, or no treatment. Results: The median age of the patients was 40 years (IQR 31.5–52), and 79.6% were female. The median disease duration of chronic spontaneous urticaria (CSU) was 4 years (IQR 2–8). The ASA provocation test was positive in 29 patients (20.4%). Positive patients had lower UCT and higher UAS7 scores (both p < 0.001). ASA provocation test positivity was more common in the antihistamine group compared to both the omalizumab ( p = 0.001) and untreated groups ( p < 0.001). ROC analysis showed that UCT ≤ 15 predicted ASA provocation test positivity with 72.4% sensitivity and 83.2% specificity, while UAS7 ≥ 4 predicted positivity with 72.4% sensitivity and 86.7% specificity. The negative predictive values (NPV) were 92.2% and 92.5%, respectively. Conclusion: To our knowledge, this is the first study to demonstrate, in a large NECD cohort, that NSAID tolerance can be achieved in patients with well‐controlled urticaria under different treatment modalities, regardless of complete remission status. UCT ≤ 15 and UAS7 ≥ 4 are useful clinical predictors of provocation test positivity and, given their high NPVs, are particularly valuable for excluding positivity.

  • Open Access

    Changes in Psychological Burden and Quality of Life During In Vivo Diagnostic Evaluation for Immediate Drug Hypersensitivity: A Prospective Stepwise Study

    by Ayşe Feyza Aslan, Semra Demir, Pelin Korkmaz, İlkim Deniz Toprak, Nevzat Kahveci, Merve Hörmet İğde, Mehmet Emin Sezgin, Bircan Erden, Deniz Eyice Karabacak, Şule Çelik Kamacı, et al.

    Background/Objective: The psychological impact of in vivo diagnostic procedures remains poorly understood. We assessed changes in psychological distress and drug hypersensitivity-related quality of life (QoL) throughout a diagnostic evaluation for suspected immediate drug hypersensitivity reactions (IDHRs) and aimed to identify predictors of persistent psychological burden. Methods: This single-center prospective observational longitudinal study included 100 consecutive adults undergoing evaluation for suspected IDHRs. Psychological distress and QoL were assessed using the Depression Anxiety Stress Scale-21 (DASS-21) and the Drug Hypersensitivity Quality of Life Questionnaire (DrHy-Q). Assessments were performed before and after each diagnostic phase, including skin tests (STs), placebo, and drug provocation tests (DPTs). Results: The mean age was 44.2 ± 12.5 years, and women comprised 72% of the cohort. Depression, anxiety, stress, and DrHy-Q scores significantly decreased after ST, placebo, and DPT compared with baseline measurements. Across diagnostic stages, depression, anxiety, stress, and DrHy-Q scores were significantly lower during the DPT phase than during the ST and placebo phase in both pre-test and post-test measurements (p < 0.01 for pairwise comparisons). The number of prior HSRs showed a weak but significant positive correlation with DrHy-Q scores. In multivariable linear regression analysis, the number of prior HSRs was the only independent predictor of post-DPT DrHy-Q scores (β = 3.43, 95% CI 1.36–5.50, p = 0.001). Patients who avoided the provoked drug despite a negative DPT had higher DPT-post depression, anxiety, stress, and DrHy-Q scores. Conclusions: Psychological burden progressively decreased over the course of the stepwise diagnostic evaluation for suspected IDHRs, although patients with repeated reactions may benefit from additional support.

  • Open Access

    CHAPLE ‐Like Enteropathy and Renal Microangiopathy in an Adult Patient With CD46 Deficiency

    by Bircan Erden, Pelin Korkmaz, Halil Yazici, Ahmet Burak Dirim, Fatih Beşışık, Nevzat Kahveci, Zeynep Kilinc, Derya Unal, Osman Ozan Yegit, Tuğba Kalaycı, et al.

    Background: Protein‐losing enteropathy is a rarely reported feature of CD46‐associated disease and may resemble CD55 deficiency with hyperactivation of complement, angiopathic thrombosis, and protein‐losing enteropathy (CHAPLE) syndrome. Associated hypogammaglobulinemia may be mistaken for primary antibody deficiency. Methods: We describe a 23‐year‐old woman with childhood‐onset enteropathy and hypogammaglobulinemia who had received immunoglobulin replacement for presumed common variable immunodeficiency since age 5. Multidisciplinary reassessment incorporated intestinal and renal histopathology, whole‐exome sequencing, family segregation, and longitudinal evaluation of the response to eculizumab. Results: Duodenal biopsy demonstrated intestinal lymphangiectasia, whereas kidney biopsy revealed chronic thrombotic microangiopathy with concurrent PLA2R‐negative membranous nephropathy. Serum C3 and C4 were within reference ranges. Sequencing identified homozygous CD46 c.565T>G (p.Tyr189Asp), with no pathogenic CD55 variant. The diagnostic laboratory reported the CD46 finding as a variant of uncertain significance. Family segregation and published functional evidence supported its clinical relevance, although patient‐specific functional confirmation was unavailable. Eculizumab promptly improved abdominal pain, vomiting, and oral intake. By April 2026, following dose escalation, serum albumin reached 4.3 g/dL and IgG 554 mg/dL, whereas proteinuria decreased from 5.95 to 2.4 g/day. Conclusion: This case supports considering CD46‐associated disease in adults with a CHAPLE‐like phenotype, particularly when enteric protein loss and hypogammaglobulinemia coexist with renal microangiopathy despite normal C3 and C4. The response to complement blockade supports a complement‐mediated disease process. Documented protein loss should prompt reassessment of a presumptive diagnosis of primary antibody deficiency.

  • Open Access

    Utility of Patch Testing, LTT, and HLA Genotyping in Identifying Culprit Drugs and Diagnosing Multiple Drug Hypersensitivity in Definite DRESS: A 10‐Year Cohort Study

    by Derya Ünal, Osman Ozan Yeğit, Semra Demir, Bircan Erden, Pelin Korkmaz, Fatma Savran Oğuz, Çiğdem Kekik Çınar, Sonay Temurhan, Deniz Eyice Karabacak, Ilkim Deniz Toprak, et al.

    Background/Aim: We evaluated the role of lymphocyte transformation test (LTT), patch testing (PT), and human leukocyte antigen (HLA) genotyping in identifying culprit drugs in Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) and assessed long‐term outcomes. Methods: DRESS was diagnosed using Registry of Severe Cutaneous Adverse Reactions (RegiSCAR) criteria; only definite cases (score > 5) were included. Severe DRESS was defined as ≥ 1 major organ involvement with clinical and laboratory abnormalities, and RegiSCAR scores supported severity assessment. Patients were grouped by single‐ or multiple drug exposure. Drug causality was assessed using the WHO‐UMC criteria. LTT, PT, and/or HLA genotyping were performed for “possible” culprit drugs. Multiple drug hypersensitivity syndrome (MDHS) was defined as hypersensitivity to ≥ 2 unrelated drugs confirmed by testing. Hypersensitivity to a single drug was classified as single‐drug hypersensitivity (SDH). Long‐term follow‐up assessed autoimmune diseases and neo‐sensitization to unrelated drugs. Results: Fifty patients with definite DRESS (median age 49 years; 50% were female) were included, and six (12%) had severe disease. Compared with non‐severe cases (mild/moderate), severe cases had higher median RegiSCAR scores (8 [7–8] vs. 6 [6–7]; p = 0.012) and more frequent facial edema ( p < 0.001) and lymphadenopathy ( p = 0.029). MDHS was more common in severe cases (83% vs. 11%; p = 0.001), and HLA risk alleles were more prevalent ( p = 0.016), including HLA‐B*58:01, HLA‐A*31:01, and HLA‐B*13:02, associated with allopurinol, carbamazepine, and levofloxacin‐induced DRESS, respectively. Among 20 patients with multiple drug exposures, 10 were diagnosed with MDHS: 5 simultaneous, 2 sequential, and 4 long‐interval; one patient exhibited both simultaneous and long‐interval reactions. Compared with SDH, MDHS patients had higher median RegiSCAR scores (7 [6–8] vs. 6 [6–8]; p < 0.001) and a higher prevalence of HLA risk alleles ( p = 0.038), including HLA‐B*58:01 (allopurinol), HLA‐A*31:01 (carbamazepine), HLA‐B*13:02 (levofloxacin) and HLA‐A*24:02 (lamotrigine). Long‐term complications occurred in eight patients: four developed autoimmune diseases, and four had neo‐sensitization leading to subsequent DRESS, considered long‐interval MDHS. Conclusion: PT and LTT effectively identified culprit drugs in DRESS, particularly in multiple drug exposure. MDHS was more frequent in severe DRESS and associated with a higher prevalence of drug‐related HLA risk alleles; however, no single HLA marker defined MDHS. Long‐term follow‐up was essential to detect autoimmune sequelae and neo‐sensitization, and to guide safe drug evaluation and reintroduction.

  • Dysmenorrhea in Chronic Spontaneous Urticaria: A Subset of Patients Report Worsening and Partial Antihistamine Benefit: UCARE HURDLE ‐I Study

    by Murat Türk, Muhammed Burak Yücel, İnSu Yılmaz, Ragıp Ertaş, Ümit Murat Şahiner, Semra Demir, Aslı Gelincik, Derya Ünal, Şule Çelik Kamacı, Merve Hörmet İğDe, et al.

    Background: Histamine plays a central role in CSU pathogenesis and may contribute to extracutaneous symptoms such as dysmenorrhea, but this relationship has not been fully examined. Methods: In this prospective, cross‐sectional multicenter study, 425 female CSU patients and 370 age‐matched controls were recruited from 19 UCARE centers in Türkiye. Dysmenorrhea prevalence and severity were assessed using a numerical scale and symptom scores. Histamine skin prick testing (SPT) was performed to evaluate histamine clearance capacity. Associations between dysmenorrhea, CSU phenotype, antihistamine use, and SPT kinetics were analyzed. Results: The prevalence and severity of dysmenorrhea were comparable between CSU patients and controls (81.6% vs. 79.5%, p = 0.244). However, 95/418 (22.7%) of CSU patients reported increased menstrual pain following CSU onset, and 20/95 (21.1%) of these reported partial relief with antihistamines. CSU patients with worsened dysmenorrhea exhibited significantly shorter histamine SPT positivity durations than those without symptom change (35 vs. 45 min; p = 0.015). No correlation was observed between dysmenorrhea severity and total IgE, anti‐TPO levels, or urticaria control/activity scores. A moderate negative correlation was found between UAS7 and elapsed time to histamine SPT negativity ( r = −0.389, p < 0.001). Conclusions: Although overall prevalence and severity of dysmenorrhea were similar in CSU patients and healthy controls, about one in five patients with CSU experienced worsening menstrual pain after disease onset, and only a subset of these patients reported partial improvement with antihistamines. A distinct CSU subgroup with heightened menstrual pain may be characterized by altered histamine dynamics. Whether these patients may benefit from more intensive antihistamine treatment remains uncertain and requires confirmation in future studies; further studies should explore neuroimmune and hormonal mechanisms underlying this overlap.

  • Open Access

    Impact of providing education on the recognition and differential diagnosis of angioedema among emergency department physicians

    by Derya Unal, Semra Demir, Sacide Rana Işik, Müge Olgaç, Raif Coşkun, Kadriye Terzioğlu, Ramazan Ersoy, Şengül Beyaz, Nida Öztop, Can Tüzer, et al.


  • Open Access

    C1 inhibitor deficient hereditary angioedema is related to endothelial dysfunction in young adult and middle‐aged patients

    by Gokce Gul Atay Sensoy, Derya Baykız, İlKim Deniz Toprak, Deniz Eyice Karabacak, Erdem Bektas, Derya Unal, Aslı Gelincik, Semra Demir

    Background: Hereditary angioedema (HAE) is a rare, autosomal dominantly inherited disease characterised by mucocutaneous oedema attacks. Vasoactive mediators and the endothelium play an important role in the pathogenesis of HAE. We aimed to evaluate the endothelial dysfunction in HAE.Methods: The study included 35 C1 inhibitor deficient (C1‐INH) HAE patients aged 18–50 years old without any risk factor that could cause endothelial dysfunction, and 25 sex‐ and age‐matched healthy controls (HCs). Bilateral carotid intima‐media thickness (CIMT), flow‐mediated dilation (FMD) measurements, and transthoracic echocardiography (ECHO) imaging were performed. Demographic and clinical features of the patients were evaluated.Results: The percentage of FMD (FMD [%]) in C1‐INH HAE patients was significantly lower than in the HCs (p < 0.001). There was no significant difference in the CIMT between C1‐INH HAE patients and HCs. In addition, the findings of the ECHO were similar between the groups. C4 and C1 INH levels at diagnosis, gender, age, disease severity, presence of long‐term prophylaxis treatment and attack frequency were not associated with FMD (%), whereas disease duration was correlated with lower FMD (%) (r = −0.480, p = 0.003).Conclusion: The present study indicated the presence of structural endothelial dysfunction in C1‐INH HAE in the absence of atherosclerosis. Moreover, the study revealed that endothelial dysfunction was associated with disease duration, irrespective of disease severity. Further studies are required in order to assess mortality and morbidity due to endothelial dysfunction in C1‐INH HAE and to determine the molecular mechanisms underlying endothelial dysfunction in C1‐INH HAE.


  • Open Access

    İstanbul park, bahçe ve korularında bulunan Mavi Atlas Sediri ağacı polenlerinin (Cedrus Atlantica Glauca) alerjenitesinin mevsimsel allerjik rinitli hastalardaki önemi

    by Özlem Yılmaz, Aslı Gelincik, Bahaüddin Çolakoğlu, Derya Ünal, Semra Demir, Suna Büyüköztürk

    Amaç: Bu çalışmanın amacı, alerjik rinit olan hastalardaki mavi atlas sediri polenine karşı olan duyarlılık ve alerjik rinit arasındaki ilişkiyi değerlendirmektir. Yöntem: Bu araştırma, İstanbul Tıp Fakültesi İç Hastalıkları Anabilim Dalı Alerji Bilim Dalı’nda Haziran-Temmuz 2014 tarihleri arasında gerçekleştirilmiştir. Çalışmaya mevsimsel alerjik rinit tanısı konmuş 22 hasta (Grup I) ve herhangi bir alerjik semptom veya hastalığı olmayan 10 sağlıklı birey (Grup II) dâhil edilmiştir. Katılımcıların İstanbul bitki örtüsünde yaygın olarak bulunan mavi atlas sediri polenlerine karşı alerjik duyarlılıkları deri prik testi ve nazal provokasyon testi ile değerlendirilmiştir. Bulgular: Mavi atlas sediri polenlerine karşı pozitif deri prik testi sonuçları Grup I’in %45,5’inde ve Grup II’de pozitiflik saptanmamıştır. Bu, iki grup arasında mavi atlas sediri polenlerine karşı pozitif deri testi yanıtı açısından istatistiksel olarak anlamlı bir fark olduğunu göstermektedir (p = 0,003). Nazal provokasyon testi Grup I’in %40,9’unda pozitif bulunurken, Grup II’deki tüm bireylerde test negatif sonuç vermiştir. Bu da iki grup arasında anlamlı bir fark olduğunu göstermektedir. Sonuç: Bu sonuçlar, mevsimsel alerjik rinitli hastalar için mavi atlas sediri polenlerinin önemli bir alerjen kaynağı olabileceğini önermektedir. İki grup arasında deri prik testi ve nazal provokasyon testi pozitiflik oranlarındaki belirgin farklar, mavi atlas sediri polenlerinin bu hastalarda alerjik rinit semptomlarını tetikleyebileceğini göstermektedir. Sağlıklı kontrol grubunda pozitif sonuçların olmaması, bulguların geçerliliğini ve alerjenin özel etkisini desteklemektedir. Çalışma ve kontrol grupları arasındaki nazal provokasyon testi sonuçlarındaki fark da benzer şekilde anlamlıydı. Bu sonuçlar, mavi atlas sediri poleninin mevsimsel alerjik rinitli hastalar için önemli bir alerjen kaynağı olabileceğini düşündürmektedir.

  • Distinct characteristics of asthma overlap phenotypes: Insights from the Turkish adult asthma registry

    by Secil Kepil Ozdemir, Bilun Gemicioglu, Fusun Yildiz, Serhat Hayme, Gulistan Alpagat, Nurgul Bozkurt, Ismet Bulut, Munevver Erdinc, Gul Karakaya, Metin Keren, et al.

    Considerable overlaps exist between asthma phenotypes and the clinical significance of these overlaps remains undetermined. The objective of this study is to analyze the characteristics of asthma overlap phenotypes using data from the Turkish Adult Asthma Registry (TAAR). This cross-sectional registry study included 2053 adult patients (74.8% female) with asthma. Overall, 39.3% (n = 697) had allergic-eosinophilic (AE), 26.0% (n = 461) had allergic-non-eosinophilic (ANE), 21.3% (n = 377) had non-allergic-eosinophilic (NAE), and 13.4% (n = 237) had non-allergic-non-eosinophilic (NANE) asthma. Severe asthma exacerbations and emergency department (ED) visits were more frequent in the AE (28.3%, 31.2%, respectively) and NAE groups (36.0%, 34.0%, respectively) than in the ANE (14.3%, 20.6%, respectively) and NANE groups (12.6%, 16.7%, respectively) (p < 0.001). FEV1 values were significantly lower in the AE group than in the ANE and NANE groups (p < 0.001, p = 0.048, respectively) and in the NAE group than in the ANE group (p < 0.001). Risk factors for poor asthma control included living in rural areas, asthma-related ED visits, FEV1 < 60% in the NAE; being overweight, chronic rhinosinusitis, oral corticosteroids use, age < 40 years in the NANE; FEV1 < 80% in the AE; and severe asthma exacerbations, ED visits for AE and ANE groups. The considerable overlap between allergic and eosinophilic asthma phenotypes has clinical implications as increased rates of asthma exacerbations and healthcare utilization. The clinical heterogeneity among asthma phenotypes based on a single biomarker highlights the importance of multidimensional asthma phenotyping.


  • Open Access

    What Does Radiologic Assessment Contribute to Asthma: A Subanalysis of the Turkish Adult Asthma Registry

    by Deniz Kizilirmak, Oguz Uzun, Derya Gokmen, Omur Aydın, Ilknur Basyigit, Adile Berna Dursun, Ilkay Koca Kalkan, Sumeyra Alan Yalim, Tugce Yakut, Gozde Koycu Buhari, et al.

    Objectives: It is aimed to assess how physicians use chest imaging in asthma and the relationship between the pathological findings and related disease characteristics in the radiological imaging of asthmatic patients. Background: The daily practice of imaging and its contribution to the management of asthma are not well defined. It is common to use radiological imaging to investigate pathologies that cause respiratory symptoms and to evaluate differential diagnoses in asthma patients. In this study, as a subanalysis of the Turkish Adult Asthma Registry, radiological findings and outcomes of asthmatic patients were examined. Methods: Between March 2018 and March 2022, the data of asthma patients in 36 secondary and tertiary health care centers was recorded using a web-based application. Patients with chest X-ray, computed thorax tomography, and paranasal sinus tomography data in the asthma database were statistically evaluated for sub-analysis. Results: The study included 2053 patients. Chest X-rays were taken in the majority of the cases (n:1739; 84.7%). Computed thorax tomography was performed in 869 (42.3%) patients and paranasal sinus tomography in 388 (18.9%) patients. The most common pathological findings on chest X-rays of asthmatic patients were increased bronchovascular branching and dirty lung appearance, whereas they were linear atelectasis, and bronchial wall thickening on computed thorax tomography bronchiectasis. Soft tissue in the sinuses and nasal polyps were the most common pathological findings in paranasal sinus tomography. Pathological findings were much more common in the radiological evaluations of patients with eosinophilic and allergic phenotypes and in patients with severe asthma. Conclusion: The radiological findings of asthma vary depending on the phenotype and severity of the disease. Patients with asthma, particularly those in the high-risk group, should be evaluated from a radiological perspective.